ReviewFrontiers in immunology2022
Toll-like receptor-targeted anti-tumor therapies: Advances and challenges.
Yang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Yang Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.